Blue Horseshoe Stocks: JNUG, RAMO & More

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve been tracking JNUG in the wake of last week’s annual low on the price of gold, and as the price of the precious metal has rebounded it has provided us with a few swing-trade opportunities.

Initially we saw JNUG run from 3.59-4.44 (+24%), and after pulling back slightly to 3.65 yesterday morning, the ETF ran back to 4.40, an intraday increase of 20% on several times the average trading volume.

We expect to witness similar patterns of activity in JNUG as long as the price of gold continues to rebound. We’re looking for it to hold support at or above $1161 (Trading in $1166-range this morning)

Ramoil Management Ltd. RAMO

We want to tag RAMO this morning and add it to our list of cannabis-related stocks; according to a PR we just caught coming over the wires, the company is set to begin clinical testing with both CBD and THC (chemical compounds found in marijuana).

It is conveniently timed with the “major hurdle” that was just cleared with regard to government approval of using cannabis for the treatment of soldiers diagnosed with PTSD. The U.S. Department of Health & Human Services has given its stamp of approval, with the measure only needing DEA clearance before becoming policy. >> Read Article in US Today

LAS VEGAS, Nov. 12, 2014 /PRNewswire/ — RAMOIL MANAGEMENT, Ltd (RAMO) wants to honor and support our veterans by announcing that RAMO Bio-Med, Inc., its wholly owned subsidiary, is beginning with controlled clinical testing of “RAMO CBD” and “RAMO THC” formulas for the treatment of Post Traumatic Stress Disorder, commonly known as PTSD. >> Full PR

Dendreon Corp. DNDN

We’ve been watching DNDN for a bounce opportunity this week, as the stock has been way oversold of late. This morning it appears as if the stock is trying to gap up slightly, so we just want to throw in a reminder that this stock could turn into a hefty bounceplay at any time.

Extended Watchlist:
SWET(News), GEVO, RADA, SUPN, SUSQ, CGG

Blue Horseshoe Stocks: Happy Veteran’s Day

Achillion Pharmceuticals, Inc. ACHN

Those of you who don’t remember, we followed ACHN to enormous gains this past summer, beginning with our first mention of the stock on June 9th. After that time we actually saw this play run from a low of 3.72 to more than 13.00.

We re-tagged it in yesterday’s extended watchlist and were happy with the timing;  the stock traded in a range from 10.67 up to 12.95, a healthy 21% intraday move on more than four times the 1-month average volume.

Planar Systems, Inc. PLNR

We also wanted to do a quick update on PLNR. This stock came off of our extended watchlist on Thursday, and made a modest 15% move from 6.11-7.05, and it put up a similar performance to start the week yesterday.

We saw a move from 6.40-7.94, an intraday gain of 24%, and at the high, an overall increase of 30% from Thursday’s observed low.

Implant Sciences Corp. IMSC

We also want to keep an eye on IMSC today, as we’re seeing the stock gap up this morning on the heels of a PR that alluded to the securing of a contract with the United States Transportation Security Administration (TSA) that apparently could be worth up to $162M.

Extended Watchlist:
ZNGA, JNUG, DNDN, LITB, THLD, ARWR

Blue Horseshoe Stocks: Recap on RPRX, JNUG, Others

Repros Therapeutics, Inc. RPRX

The primary attraction to come off of our report on Friday was definitely RPRX. The stock had one heck of a solid session, building steadily all day long. It traded from a morning low of 7.66, and reached as high as 10.25 just prior to the close, and did so on volume which exceeded the 3-month average by nearly eight times. That’s a really impressive run from a stock in this price range.

We originally caught RPRX on October 17th after catching the stock gapping down to 52-week lows, and measuring from the low we observed subsequent to that report (5.97), Friday’s high represented an overall increase of 71%

The company is slated to release earnings today >> View Earnings Calendar

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

Also jumping off of Friday’s extended watchlist with a good showing was JNUG. We seemed to have timed our mention of this ETF quite well, with gold prices having bounced off of their annual low on Thursday, it set the stage for JNUG to make a respectable intraday day for us.

It traded in a range from 3.59-4.44, gaining as much as 24% on considerable volume, to the tune of 4.5X it’s 3-month average.

JNUG could be an interesting play moving forward providing the rebound in the price of gold is sustained, so that will be one of the things we’ll be interested to watch for as we kick off a new trading week.

Dendreon Corp. DNDN

DNDN is taking a massive premarket pounding this morning in the wake of the company’s filing for Chapter 11 protection. It’s worth noting, despite the forthcoming restructuring, the company will continue to produce and distribute its PROVENGE immunotherapy treatment, and has declared that it “has significant liquidity to support all of its operations during the restructuring process, with approximately $100 million of cash, cash equivalents and investments on hand as of November 7, 2014” >> View PR

Because of the nature of the situation, we’ll be exercising extreme caution, but we still want to monitor the stock for a bottom and subsequent bounceplay opportunities that could come as a result.

Extended Watchlist:
ACHN, IBIO, ARQL, DVAX, UEC, OIBR